WASHINGTON (May 13, 2019) — Together with the United States Food and Drug Administration (FDA) and the BioCompute Partnership, the George Washington University is co-sponsoring a workshop, titled “BioCompute Objects: Tools for Communicating Next Generation Sequencing Data and Analysis.”
This year’s panel discussion will focus on how next generation sequencing analysis methods are currently handled and communicated to the FDA, what the challenges are, and where BioCompute fits in. There will be an update on the standardization of BioCompute through the International Organization for Standardization and the Institute of Electrical and Electronics Engineers, and the establishment of the BioCompute Public Private Partnership. The workshop will also serve as the kickoff for a BioCompute Object Challenge on PrecisionFDA — a cloud-based DNA sequencing data platform — for coders and bioinformaticians.
All interested parties, including members of the general public interested in learning more about BioCompute, are welcome to join. Space is limited and will be offered on a first come, first serve basis. The workshop will also be accessible via WebEx.
WHAT: 2019 BioCompute Workshop: Tools for Communicating Next Generation Sequencing Data and Analysis
WHEN: Tuesday, May 14, 9 a.m.–5 p.m.
WHERE: FDA White Oak Campus; 10903 New Hampshire Ave., White Oak, Maryland
MEDIA: Please contact Lisa Anderson at 202-994-3121 or email@example.com to attend the event
- The event can be accessed remotely through WebEx at fda.gov/biocompute/
Available for logged-in reporters only